Physostigmine and modulators of nitric oxide system on the mean arterial pressure of the spontaneously hypertensive rat

General Pharmacology

Volumn 28, Issue 1, 1997, Pages 105-112

  Prostran, Milica Š ^a   Todorović, Zoran ^a   Varagić, Vladislav M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

central cholinergically mediated hypertension (CCMH); L arginine; L NAME; NO system; physostigmine; SHR

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PHYSOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; FEMALE; HEREDITARY HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031021411     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00158-9     Document Type: Article

References (41)

1. G -nitro-L-arginine methyl ester on cirazoline- and KCl-induced responses in the perfused mesenteric arterial bed of rats. Br. J. Pharmacol. 111, 13-20.
2. Adeagbo A. S. O. and Triggle C. R. (1993) Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta. Br. J. Pharmacol. 109, 495-501.
3. Anggard E. (1994) Nitric oxide: mediator, murderer, and medicine. Lancet 343, 1199-1206.
4. Arnal J. F., Battle T., Menard J. and Michel J. B. (1993a) The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spontaneously hypertensive rat. J. Hypertens. 11, 945-950.
5. Arnal J. F., Battle T., Menard J. and Michel J. B. (1993b) L'effet vasodilatateur de l'oxide d'azote est une contre-regulation indispensable chez le rat spontanement hypertendu. Arch. Mal. Coeur Vaiss 86, 1193-1196.
6. Botting R. and Vane J. R. (1990) The role of endothelium in vascular homeostasis. In Endothelium-Derived Relaxing Factors. (Edited by Rubanyi G. M. and Vanhoutte P. M.) pp. 1-7. Karger, Basel-München-Paris-London.
7. Brezenoff H. E. and Giuliano R. (1982) Cardiovascular control by cholinergic mechanisms in the central nervous system. Ann. Rev. Pharmacol. Toxicol. 22, 341-381.
8. Brezenoff H. E., Vargas H. and Xiao Y.-F. (1988) Blockade of brain M2 muscarinic receptors lowers blood pressure in spontaneously hypertensive rats. Pharmacology, 36, 101-105.
9. Cocks T. M. and Angus J. A. (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305, 627-630.
10. Fernandez N., Monge L., Garcia-Villalon A. L., Garcia J. L., Gomez B. and Dieguez G. (1994) Cooling effects on nitric oxide production by rabbit ear and femoral arteries during cholinergic stimulation. Br. J. Pharmacol. 113, 550-554.
11. Fineman J. R., Chang R. and Soifer S. J. (1991) L-Arginine, a precursor of EDRF in vitro, produces pulmonary vasodilation in lambs. Am. J. Physiol. 261 (Heart Circ. 30), H1563-H1569.
12. G -nitro-L-arginine methyl ester in conscious, Long Evans rats. Br. J. Pharmacol. 101, 625-631.
13. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
14. G -nitro-arginine. Br. J. Pharmocol. 102, 565-566.
15. Kelm M., Feelisch M., Krebber T., Motz W. and Strauer B.E. (1992) The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 20, 183-186.
16. Khraibi A. A. (1994) Inhibition of nitric oxide causes exaggerated natriuresis in spontaneously hypertensive rats. Am. J. Physiol. 266(5 Pt 2), F762-F766.
17. McCall T. and Vallance P. (1992) Nitric oxide takes center-stage with newly defined roles. Trends Pharmacol. Sci. 13, 1-6.
18. Mantelli L., Amerini S. and Ledda F. (1995) Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J. Cardiovasc. Pharmacol. 25, 595-602.
19. Martin W., Furchgott R. F., Vilani G. M. and Jothianandan D. (1986) Depression of contractile responses in the rat aorta by spontaneously released endothelium-derived factor. J. Pharmacol. Exp. Ther. 237, 529-538.
20. Moncada S., Palmer R. M. J. and Higgs E. A. (1989) Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38, 1709-1715.
21. Moncada S., Palmer R. M. J. and Higgs E. A. (1990) Discovery and biological relevance of the L-arginine-nitric oxide pathway. In Endothelium-Derived Relaxing Factors (Edited by Rubanyi G. M. and Vanhoutte P. M.) pp. 55-63. Karger, Basel-München-Paris-London.
22. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
23. Morikawa E., Moskowitz M. A., Huang Z., Yoshida T., Irikura K. and Dalkara T. (1994) L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25, 429-435.
24. Nikolić J., Stepanović S., Dronjak S., Oprŝalova Z. and Varagić V. M. (1992) Effects of physostigmine and immobilization stress on plasma catecholamines in spontaneously hypertensive rats (SHR) after electrocoagulation of the Locus coeruleus. In Stress-Neuroendocrine and Molecular Approaches (Edited by Kvetnansky R., McCarty R. and Axelrod J.) pp. 553-560. Gordon and Breach Sc. Publ., New York.
25. Prast H., Fischer H., Werner E., Werner-Felmayer G. and Philippu A. (1995) Nitric oxide modulates the release of acetylcholine in the ventral striatum of the freely moving rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 67-73.
26. G -nitro-L-arginine methyl ester (L-NAME) on the mean arterial pressure of the rat. J. Basic Clin. Physiol. Pharmacol. 5, 151-166.
27. Rees D. D., Palmer R. M. J. and Moncada S. (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 86, 3375-3378.
28. Schulz R. and Triggle C. R. (1994) Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol. Sci. 15, 255-259.
29. ω -nitro-L-arginine methyl on pressor responses elicited by sympathetic nerve stimulation in pithed normotensive and hypertensive rats. Life Sci. 49, 1989-1995.
30. Vallance P., Leone A., Carver A., Collier J. and Moncada S. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572-575.
31. G -nitro-L-arginine methyl ester in rats and cats. Br. J. Pharmacol. 103, 1899-1904.
32. Varagić V. M. (1955) The action of eserine on the blood pressure of the rat. Br. J. Pharmacol. 10, 349-353.
33. Varagić V. M., Kazić T. and Rosić N. (1968) Inversion of physostigmine hypertension by paraoxon and DFP. Iugoslav. Physiol. Pharmacol. Acta 4, 113-120.
34. Varagić V. M. and Prostran M. (1989) Neurotransmitter interactions and modulation of cell functions, Iugoslav. Physiol. Pharmacol. Acta 25, 15-33.
35. Varagić V. M., Zugić M. and Kentera D. (1969) The effect of eserine on some circulatory parameters in the rat. Iugoslav. Physiol. Pharmacol. Acta 5, 59-69.
36. Varagić V. M. and Prostran M. (1991) Modulating effect of adenosine on the hypertensive response to physostigmine. Arch. Int. Pharmacodyn. Ther. 311, 144-154.
37. Varagić V. M., Prostran M. S., Stepanović S., Savić J. and Vujnov S. (1991) Transmitter interactions in the central cholinergic control of blood pressure regulation. Drug Metab. Drug Interac. 9, 49-76.
38. Vargas H. M., Ignarro L. J. and Chaudhuri G. (1990) Physiological release of nitric oxide is dependent on the level of vascular tone. Eur. J. Pharmacol., 190, 393-397.
39. G -nitro-L-arginine and diphenyleneiodonium. Br. J. Pharmacol. 114, 194-202.
40. Xiao J. and Pang P. K. (1994) Does a general alteration in nitric oxide synthesis occur in spontaneously hypertensive rats. Am. J. Physiol. 266, H272-H278.
41. Zorumski C. F. and Igumi Y. (1993) Nitric oxide and hippocampal synaptic plasticity. Biochem. Pharmacol. 46, 777-785.